Suppr超能文献

从泡菜中分离出的Wilac L复合益生菌对人体酒精和乙醛代谢调节的有效性及安全性

Efficacy and Safety of Wilac L Probiotic Complex Isolated from Kimchi on the Regulation of Alcohol and Acetaldehyde Metabolism in Humans.

作者信息

Sun Hwayeon, Park Sangmin, Mok Jiye, Seo Jeonghyun, Lee Nicole Dain, Yoo Byungwook

机构信息

Microbiome R&D Center, Pharmsville, Co., Ltd., Seoul 07793, Republic of Korea.

School of Medicine, Georgetown University, Washington, DC 20007, USA.

出版信息

Foods. 2024 Oct 16;13(20):3285. doi: 10.3390/foods13203285.

Abstract

Alcohol-related hangovers impact both physical and mental wellness, largely due to acetaldehyde levels produced through alcohol metabolism. The present study investigated the efficacy and safety of the Wilac L probiotic complex ( WiKim0168 and WiKim0172 isolated from kimchi) in improving hangovers post-alcohol consumption. This study was conducted as a randomized, double-blind, crossover placebo-controlled clinical trial from August 2023 to February 2024. Subjects ( = 26) were randomized into six test groups consuming three products, the Wilac L probiotic complex, Wilac L35 (Wilac L probiotic complex with Nakai), or placebo, in different orders with crossover after a wash-out interval of 7-10 days. Blood alcohol and acetaldehyde concentrations were measured 0, 0.25, 0.5, 1, 2, 4, 6, and 15 h after alcohol consumption. The blood acetaldehyde levels measured with Wilac L probiotic complex supplementation were significantly lower than the control at 0.25 ( = 0.0381), 0.5 ( = 0.0498), and 1 h ( = 0.0260) post-consumption. The blood acetaldehyde levels after Wilac L35 consumption compared to the control are significant at 0.25 ( = 0.0115), 0.5 ( = 0.0054), 1 ( = 0.0285), 2 ( = 0.0113), and 6 h ( = 0.0287) post-consumption. No significant adverse events were reported. The Wilac L probiotic complex is associated with decreased blood acetaldehyde levels and improved subjective hangover symptoms.

摘要

与酒精相关的宿醉会影响身心健康,这主要是由于酒精代谢产生的乙醛水平所致。本研究调查了Wilac L益生菌复合物(从泡菜中分离出的WiKim0168和WiKim0172)在改善饮酒后宿醉方面的功效和安全性。本研究于2023年8月至2024年2月作为一项随机、双盲、交叉安慰剂对照临床试验进行。受试者(n = 26)被随机分为六个测试组,以不同顺序服用三种产品,即Wilac L益生菌复合物、Wilac L35(含中井的Wilac L益生菌复合物)或安慰剂,在7 - 10天的洗脱期后进行交叉。在饮酒后0、0.25、0.5、1、2、4、6和15小时测量血液中的酒精和乙醛浓度。补充Wilac L益生菌复合物后测得的血液乙醛水平在饮酒后0.25小时(p = 0.0381)、0.5小时(p = 0.0498)和1小时(p = 0.0260)显著低于对照组。与对照组相比,服用Wilac L35后血液乙醛水平在饮酒后0.25小时(p = 0.0115)、0.5小时(p = 0.0054)、1小时(p = 0.0285)、2小时(p = 0.0113)和6小时(p = 0.0287)有显著差异。未报告重大不良事件。Wilac L益生菌复合物与血液乙醛水平降低和主观宿醉症状改善有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3883/11507351/328478cb9902/foods-13-03285-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验